MDNAF
Medicenna Therapeutics Corp.
$0.28
-0.03 (-8.64%)
At close · Jul 2
Market Cap
$25.38M
Shares
69,637,469
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.28
Open$0.28
Day$0.27–0.28
52W$0.25–1.43
Avg vol 30d65K
Short int710K · 1.0% float · 4.0d
Short vol72%
DataJan 2020–Jul 2026
Equibles Rating
blended score · not investment advice
Overall
Neutral
Technical · trend & momentum
Sell
◦
50 / 200-day cross
no cross
−
Price vs 200-day avg
−57% below
−
Price vs 50-day avg
−23% below
◦
RSI (14)
37 · neutral
+
MACD trend
positive
−
52-week position
2% · near low
Sentiment · smart money
Bullish
◦
Trend (MA cross)
50d $0 › 200d $1 — 200d above 50d
◦
Institutional flow
0% holders QoQ
◦
Insider flow
No net insider activity over 90 days
+
Short interest
1.02% of float · ▼ -2.9% MoM · 4.0 days cover
◦
Volume signal
Volume near normal
◦
Institution breadth
1 holders — near 3-yr low, contrarian setup
Fundamentals
Limited data
Not enough data for a confident read.
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Up next
FQ2-27 quarter ends
~Sep 30, 2026
Est
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
no cross
Neutral
Price vs 200-day avg
−57% below
Bearish
Price vs 50-day avg
−23% below
Bearish
RSI (14)
37 · neutral
Neutral
MACD trend
positive
Bullish
52-week position
2% · near low
Bearish
Market signals — smart money & positioning
Bullish · 1 of 6
Trend (MA cross)
No cross
50d $0 › 200d $1 — 200d above 50d
Institutional flow
Flat
0% holders QoQ
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
1.02% of float · ▼ -2.9% MoM · 4.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
1 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
52-wk low $0
Now $0 · 2%
52-wk high $1
vs 200-day avg -57%
vs 50-day avg -23%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
MDNAF
this stock
Medicenna Therapeutics Corp.
|
$25.38M | -59.3% | — | — | 1.0% |
|
AKTX
Akari Therapeutics Plc
|
$953.21B | -9.9% | — | — | 0.0% |
|
ONC
BeOne Medicines Ltd.
|
$470.30B | -2.0% | +22179.2% | 957.1 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$134.02B | +16.5% | +46.2% | 31.3 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$69.80B | -15.1% | +20.8% | 16.3 | 3.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Accumulating
Holders
1
- % held
- 0.3%
- Net QoQ
- +50.0K sh
- Top holder
- ORG Partners LLC
Held
Float
Short & Settlement
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| MDNAF | -5.5% | -16.7% | -59.4% | +0.0% | -59.3% |
| SPY | +1.4% | -1.3% | +8.0% | -0.3% | +9.2% |
| vs SPY | -6.9% | -15.4% | -67.5% | +0.3% | -68.5% |